New York, NY -- (SBWIRE) -- 02/25/2013 -- EDAP TMS SA (NASDAQ: EDAP) announced new long term data demonstrating high rates of both cancer-specific survival, and freedom from salvage therapy for patients treated with high-intensity focused ultrasound (HIFU) therapy.
The study was performed by Drs. Stefan Thurroff and Christian Chaussy and evaluated the cancer control and morbidity of HIFU, in combination with transurethral resection of the prostate prior to treatment, over a 15 year period. The study was electronically published in February 2013 by the Journal of Urology, the Official Journal of the American Urological Association.
EDAP TMS SA develops and markets Ablatherm(R), the most advanced and clinically proven choice for high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer.
Find out more on EDAP by getting the free trend analysis report here: http://www.monstertradingalerts.com/market-scan/?symbol=EDAP
pSivida Corp. (NASDAQ: PSDV) announced earlier this month its financial results for its second quarter ended December 31, 2012.
Revenues for the fiscal 2013 second quarter were $585,000 compared to $630,000 for the second quarter last year. The Company reported a net loss of $2.6 million, or $0.11 per share, for the second quarter ended December 31, 2012, compared to a net loss of $17.5 million, or $0.84 per share, for the second quarter of the prior year. The prior year net loss included a $14.8 million impairment write-down of the Company’s finite-lived intangible assets.
pSivida Corp., headquartered in Watertown, MA, develops tiny, sustained release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.
Find out where PSDV could be headed by getting the free trend analysis report here: http://www.monstertradingalerts.com/market-scan/?symbol=PSDV
MonsterTradingAlerts.com issues momentum alerts on stocks that can provide gains to day traders. MonsterTradingAlerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. MonsterTradingAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals MonsterTradingAlerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the MonsterTradingAlerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.MonsterTradingAlerts.com
Disclosure: MonsterTradingAlerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit MonsterTradingAlerts.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit; http://www.monstertradingalerts.com/disclaimer/
Alexander K. Neumann
Monster Trading Alerts